Months | Serogroup | Study participants | Healthy controls | P |
---|---|---|---|---|
0 | n = 26 | n = 75 | ||
MenA | 0.1; 0.1–0.21 | 0.6; 0.5–0.81 | < 0.01* | |
MenC | 0.5; 0.2–1.0 | 0.3; 0.3–0.5 | 0.36 | |
MenW | 0.0; 0.0–0.1 | 0.2; 0.1–0.3 | < 0.01* | |
MenY | 0.0; 0.0–0.1 | 0.1; 0.1–0.1 | 0.23 | |
3–6 | n = 45 | n = 0 | ||
MenA | 5.3; 3.3–8.7 | - | - | |
MenC | 38.5; 22.5–65.8 | - | - | |
MenW | 1.5; 0.9–2.5 | - | - | |
MenY | 3.0; 1.7–5.5 | - | - | |
12 | n = 47 | n = 75 | ||
MenA | 2.5; 1.6–3.7 | 8.2; 6.5–10.4 | < 0.01* | |
MenC | 14.6; 9.4–22.51 | 16.9; 14.0–20.4 | 0.53 | |
MenW | 1.1; 0.7–1.8 | 4.5; 3.3–6.3 | < 0.01* | |
MenY | 2.1; 1.3–3.7 | 2.5; 1.7–3.8 | 0.60 | |
24 | n = 39 | n = 0 | ||
MenA | 1.2; 0.8–2.0 | - | - | |
MenC | 5.6; 3.1–10.2 | - | - | |
MenW | 0.4; 0.3–0.7 | - | - | |
MenY | 1.0; 0.6–1.7 | - | - |